Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03820050 · ClinicalTrials.gov registry record
FreeStyle LIbre Flash Glucose Monitoring System Pediatric Accuracy Study
A clinical trial, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- 144
- Enrollment target
NCT03820050: Completed study, sponsored by Abbott Diabetes Care.
NCT03820050 is a clinical trial that has completed, run by Abbott Diabetes Care. The registered enrollment target is 144 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03820050 has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- 144 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the Freestyle Libre Flash Glucose Monitoring System in pediatric subjects with respect to YSI reference venous plasma sample measurements.
Primary Outcome
System Performance will be characterized with respect to YSI reference venous plasma measurements
Interventions
- DEVICE Freestyle LIbre Flash Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2019-01-29 |
| Est. Completion | 2019-06-14 |
What the finished NCT03820050 record still lists
NCT03820050 is an observational study that tracks outcomes without assigning an intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Freestyle LIbre Flash Glucose Monitoring System is the first listed.
NCT03820050 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03820050 about?
NCT03820050 is a clinical study titled "FreeStyle LIbre Flash Glucose Monitoring System Pediatric Accuracy Study". The purpose of this study is to characterize the Freestyle Libre Flash Glucose Monitoring System in pediatric subjects with respect to YSI reference venous plasma sample measurements.
What is the current status of trial NCT03820050?
This trial is currently completed. The enrollment target is 144 participants. The study started on 2019-01-29. Estimated completion is 2019-06-14.
What interventions are being tested in trial NCT03820050?
The interventions under investigation include: Freestyle LIbre Flash Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT03820050?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI